MedTrace Logo

Coronary Flow Reserve Changes After Semaglutide Treatment

NCT07190144 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2025-09-24

No results posted yet for this study

Summary

The goal of this observational study is to learn about the effects of semaglutide to coronary artery flow in diabetic and non-diabetic patients. The main question it aims to answer is:

Does semaglutide enhance coronary artery flow in diabetic and non-diabetic patients?

Participants already planned taking semaglutide by an endocrine specialist as their treatment was assessed with CFR before and 3 months after.

Conditions

  • The Study Focused on the Vascular Effects of Semaglutide in Both Diabetic and Non-diabetic Patients
  • Obesity &Amp; Overweight

Sponsors & Collaborators

  • MEDICANA

    collaborator UNKNOWN

  • Ekrem Bilal Karaayvaz

    lead OTHER

Eligibility

Min Age
28 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-07
Primary Completion
2025-08-01
Completion
2025-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07190144 on ClinicalTrials.gov